APA (7th ed.) Citation

Khalilieh, S., Yee, K. L., Liu, R., Fan, L., Sanchez, R. I., Auger, P., . . . Merck. (2016). Moderate Hepatic Impairment Does Not Affect Doravirine Pharmacokinetics ; Khalilieh et al. The Journal of Clinical Pharmacology ; volume 57, issue 6, page 777-783 ; ISSN 0091-2700. https://doi.org/10.1002/jcph.857

Chicago Style (17th ed.) Citation

Khalilieh, Sauzanne, et al. "Moderate Hepatic Impairment Does Not Affect Doravirine Pharmacokinetics ; Khalilieh Et Al." The Journal of Clinical Pharmacology ; Volume 57, Issue 6, Page 777-783 ; ISSN 0091-2700 2016. https://doi.org/10.1002/jcph.857.

MLA (9th ed.) Citation

Khalilieh, Sauzanne, et al. "Moderate Hepatic Impairment Does Not Affect Doravirine Pharmacokinetics ; Khalilieh Et Al." The Journal of Clinical Pharmacology ; Volume 57, Issue 6, Page 777-783 ; ISSN 0091-2700, 2016, https://doi.org/10.1002/jcph.857.